Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Although lymph node metastasis is a poor prognostic factor in patients with pancreatic ductal adenocarcinoma (PDAC), our understanding of lymph node size in association with PDAC is limited. Increased nodal size in preoperative imaging has been used to detect node metastasis. We evaluated whether lymph node size can be used as a surrogate preoperative marker of lymph node metastasis. Methods: We assessed nodal size and compared it to the nodal metastatic status of 200 patients with surgically resected PDAC. The size of all lymph nodes and metastatic nodal foci were measured along the long and short axis, and the relationships between nodal size and metastatic status were compared at six cutoff points. Results: A total of 4,525 lymph nodes were examined, 9.1% of which were metastatic. The mean size of the metastatic nodes (long axis, 6.9 ± 5.0 mm; short axis, 4.3 ± 3.1 mm) was significantly larger than that of the non-metastatic nodes (long axis, 5.0 ± 4.0 mm; short axis, 3.0 ± 2.0 mm; all p < .001). Using a 10 mm cutoff, the sensitivity, specificity, positive predictive value, overall accuracy, and area under curve was 24.8%, 88.0%, 17.1%, 82.3%, and 0.60 for the long axis and 7.0%, 99.0%, 40.3%, 90.6%, and 0.61 for the short axis, respectively. Conclusions: The metastatic nodes are larger than the non-metastatic nodes in PDAC patients. However, the difference in nodal size was too small to be identified with preoperative imaging. The performance of preoperative radiologic imaging to predict lymph nodal metastasis was not good. Therefore, nodal size cannot be used a surrogate preoperative marker of lymph node metastasis.
Abstract
Background: Although lymph node metastasis is a poor prognostic factor in patients with pancreatic ductal adenocarcinoma (PDAC), our understanding of lymph node size in association with PDAC is limited. Increased nodal size in preoperative imaging has been used to detect node metastasis. We evaluated whether lymph node size can be used as a surrogate preoperative marker of lymph node metastasis. Methods: We assessed nodal size and compared it to the nodal metastatic status of 200 patients with surgically resected PDAC. The size of all lymph nodes and metastatic nodal foci were measured along the long and short axis, and the relationships between nodal size and metastatic status were compared at six cutoff points. Results: A total of 4,525 lymph nodes were examined, 9.1% of which were metastatic. The mean size of the metastatic nodes (long axis, 6.9 ± 5.0 mm; short axis, 4.3 ± 3.1 mm) was significantly larger than that of the non-metastatic nodes (long axis, 5.0 ± 4.0 mm; short axis, 3.0 ± 2.0 mm; all p < .001). Using a 10 mm cutoff, the sensitivity, specificity, positive predictive value, overall accuracy, and area under curve was 24.8%, 88.0%, 17.1%, 82.3%, and 0.60 for the long axis and 7.0%, 99.0%, 40.3%, 90.6%, and 0.61 for the short axis, respectively. Conclusions: The metastatic nodes are larger than the non-metastatic nodes in PDAC patients. However, the difference in nodal size was too small to be identified with preoperative imaging. The performance of preoperative radiologic imaging to predict lymph nodal metastasis was not good. Therefore, nodal size cannot be used a surrogate preoperative marker of lymph node metastasis.
참고문헌 (24)
- Roth MT, "Current concepts in the treatment of resectable pancreatic cancer", Curr Oncol Rep, 20, pp.39~ (2018)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2018", Cancer Research and Treatment, 50(2), pp.317~323 (2018), 대한암학회
- Siegel RL, "Cancer statistics, 2019", CA Cancer J Clin, 69, pp.7~34 (2019)
- Hernandez JM, "The natural history of resected pancreatic cancer without adjuvant chemotherapy", Am Surg, 76, pp.480~485 (2010)
- Lowder CY, "Clinical implications of extensive lymph node metastases for resected pancreatic cancer", Ann Surg Oncol, 25, pp.4004~4011 (2018)
- Allen PJ, "Multi-institutional validation study of the American Joint Commission on Cancer(8th Edition)changes for T and N staging in patients with pancreatic adenocarcinoma", Ann Surg, 265, pp.185~191 (2017)
- Konstantinidis IT, "Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?", J Gastrointest Surg, 14, pp.261~267 (2010)
- Murakami Y, "Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma", J Am Coll Surg, 211, pp.196~204 (2010)
- Amin MB, "AJCC cancer staging manual" (2017), Springer
- Li HJ, "Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification : a retrospective cohort study", Medicine (Baltimore), 97, pp.e12094~ (2018)
- Schwarz RE, "Extent of lymph node retrieval and pancreatic cancer survival : information from a large US population database", Ann Surg Oncol, 13, pp.1189~1200 (2006)
- Tomlinson JS, "Accuracy of staging nodenegative pancreas cancer : a potential quality measure", Arch Surg, 142, pp.767~723 (2007)
- van der Valk P, "Histology for pathologists", pp.820~828 (2012), Lippincott Williams &Wilkins
- Prenzel KL, "Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head", Eur J Surg Oncol, 36, pp.993~996 (2010)
- Roche CJ, "CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas", AJR Am J Roentgenol, 180, pp.475~480 (2003)
- Megibow AJ, "Pancreatic adenocarcinoma : CT versus MR imaging in the evaluation of resectability : report of the Radiology Diagnostic Oncology Group", Radiology, 195, pp.327~332 (1995)
- Muller MF, "Pancreatic tumors : evaluation with endoscopic US, CT, and MR imaging", Radiology, 190, pp.745~751 (1994)
- Midwinter MJ, "Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours", Br J Surg, 86, pp.189~193 (1999)
- Palazzo L, "Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma : results of a prospective study with comparison to ultrasonography and CT scan", Endoscopy, 25, pp.143~150 (1993)
- Zeman RK, "TNM staging of pancreatic carcinoma using helical CT", AJR Am J Roentgenol, 169, pp.459~464 (1997)
- Rosch T, "Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography", Gastroenterology, 102, pp.188~199 (1992)
- Al-Hawary MM, "Pancreatic ductal adenocarcinoma radiology reporting template : consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association", Radiology, 270, pp.248~260 (2014)
- Rosai J, "Rosai and Ackerman’s surgical pathology" (2011), Mosby Elsevier
- Tran T, "Correcting the shrinkage effects of formalin fixation and tissue processing for renal tumors : toward standardization of pathological reporting of tumor size", J Cancer, 6, pp.759~766 (2015)